Related Experiment Video
Updated: Jan 11, 2026

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Decreasing the Epilepsy Treatment Gap in Tena, Ecuador: A Report From 2021 to 2023
Grace Bayas1, Gema Bayas2, Angel Bayas3
1Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA.
None:
Background Neurological care in rural areas such as Tena, Ecuador, remains critically low due to geographic, economic, and systemic barriers. Tena, located in the Amazon region, has limited access to specialized neurological services, creating significant health disparities. Since 2009, the International Neurology Foundation (INF) has partnered with the Hospital José María Velasco Ibarra to address these challenges. Methodology This retrospective analysis summarizes data from the INF medical service relief trip (MSRT) conducted in Tena from 2021 to 2023. Clinical records, interviews with providers, and MSRT reports were reviewed to assess patient demographics, diagnoses, treatments, and interventions. Descriptive statistics and thematic analysis were used to identify trends and insights. Results Over three years, 751 patients were treated, with epilepsy being the most common diagnosis (265 cases). Children under the age of 10 years represented the largest patient group. Key achievements included the donation of electroencephalography equipment, enabling local epilepsy diagnostics, and training local healthcare providers. Persistent challenges included limited imaging resources, inconsistent medication supply, and barriers related to language and transportation. Conclusions INF's initiatives have significantly improved access to neurological care in Tena, enhancing diagnostic capabilities and providing critical training. Sustainable progress requires investment in infrastructure, expanded training programs, and consistent medication availability. The Tena experience serves as a model for reducing health disparities and improving neurological care in resource-limited settings, aligning with global health equity priorities.
More Related Videos
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Electroconvulsive Therapy
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

